These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1919549)

  • 1. Three cases of pharmacotherapy of obsessive-compulsive disorder in the elderly.
    Austin LS; Zealberg JJ; Lydiard RB
    J Nerv Ment Dis; 1991 Oct; 179(10):634-5. PubMed ID: 1919549
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine].
    Volk S
    Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():28-32. PubMed ID: 7635392
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluvoxamine in obsessive-compulsive nonresponders to clomipramine or fluoxetine.
    Mattes JA
    Am J Psychiatry; 1994 Oct; 151(10):1524. PubMed ID: 8092352
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
    Pigott TA; Pato MT; Bernstein SE; Grover GN; Hill JL; Tolliver TJ; Murphy DL
    Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine-clomipramine interaction.
    Sternbach H
    J Clin Psychiatry; 1995 Apr; 56(4):171-2. PubMed ID: 7713858
    [No Abstract]   [Full Text] [Related]  

  • 6. Clomipramine versus fluoxetine in obsessive-compulsive disorder: a retrospective comparison of side effects and efficacy.
    Jenike MA; Baer L; Greist JH
    J Clin Psychopharmacol; 1990 Apr; 10(2):122-4. PubMed ID: 2140372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
    Simeon JG; Thatte S; Wiggins D
    Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced mania.
    Mundo E; Ronchi P; Bellodi L
    Hosp Community Psychiatry; 1993 Jul; 44(7):689-90. PubMed ID: 8354514
    [No Abstract]   [Full Text] [Related]  

  • 9. Paranoid and aggressive behavior in two obsessive-compulsive adolescents treated with clomipramine.
    Alarcon RD; Johnson BR; Lucas JP
    J Am Acad Child Adolesc Psychiatry; 1991 Nov; 30(6):999-1002. PubMed ID: 1757451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obsessive disorder with self-mutilation: a subgroup responsive to pharmacotherapy.
    Primeau F; Fontaine R
    Can J Psychiatry; 1987 Nov; 32(8):699-701. PubMed ID: 3500773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of obsessive-compulsive disorder and trichotillomania to serotonin reuptake blockers.
    Graae F; Gitow A; Piacentini J; Jaffer M; Liebowitz M
    Am J Psychiatry; 1992 Jan; 149(1):149-50. PubMed ID: 1728180
    [No Abstract]   [Full Text] [Related]  

  • 12. The benefits of clomipramine-fluoxetine combination in obsessive compulsive disorder.
    Browne M; Horn E; Jones TT
    Can J Psychiatry; 1993 May; 38(4):242-3. PubMed ID: 8518974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine treatment of obsessive-compulsive disorder.
    Solyom L; Solyom C; Ledwidge B
    Can J Psychiatry; 1991 Dec; 36(10):723-7. PubMed ID: 1790516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorder.
    Hollander E; Stein DJ; DeCaria CM; Saoud JB; Klein DF; Liebowitz MR
    Biol Psychiatry; 1993 May; 33(10):747-9. PubMed ID: 8353170
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiobsessive effect of fluoxetine.
    Fontaine R; Chouinard G
    Am J Psychiatry; 1985 Aug; 142(8):989. PubMed ID: 3875293
    [No Abstract]   [Full Text] [Related]  

  • 16. Olfactory reference syndrome responds to clomipramine but not fluoxetine: a case report.
    Dominguez RA; Puig A
    J Clin Psychiatry; 1997 Nov; 58(11):497-8. PubMed ID: 9413419
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacotherapy of obsessive-compulsive disorder.
    Jermain DM; Crismon ML
    Pharmacotherapy; 1990; 10(3):175-98. PubMed ID: 2196535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder.
    Diniz JB; Costa DL; Cassab RC; Pereira CA; Miguel EC; Shavitt RG
    J Psychopharmacol; 2014 Jun; 28(6):603-11. PubMed ID: 24288238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clomipramine, fluoxetine, and behavior therapy in the treatment of obsessive-compulsive disorder: a meta-analysis.
    Cox BJ; Swinson RP; Morrison B; Lee PS
    J Behav Ther Exp Psychiatry; 1993 Jun; 24(2):149-53. PubMed ID: 8263222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of drug treatment response in obsessive-compulsive disorder.
    Ravizza L; Barzega G; Bellino S; Bogetto F; Maina G
    J Clin Psychiatry; 1995 Aug; 56(8):368-73. PubMed ID: 7635854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.